Current know ledge about factors determining outcome of asthma is limited,
but observations over the last fen. decades suggest that active asthma has
a negative impact on the longitudinal changes in lung function. This review
aims to give an overview of the present knowledge concerning longitudinal
changes in lung function, including clinical markers for distinctly poor ou
tcome with regard to lung function, in children and adults suffering from a
sthma.
The majority of patients with asthma have a good prognosis. However, some p
atients with asthma, especially those with more severe disease, are at risk
of impaired growth of lung function during childhood, a lower maximally at
tained level of lung function and excessive decline in lung function in adu
lthood, which may lead to life-threatening lung function impairment. Clinic
al markers of poorly controlled airway inflammation appear to have a negati
ve impact on the longitudinal changes in lung function, and disease progres
sion to nonreversible airflow obstruction may be observed in a minority of
patients with asthma.
Early intervention with anti-inflammatory therapy may improve the short-ter
m outcome of asthma, but long-term controlled studies are clearly needed in
order to verify whether or not treatment, especially with inhaled corticos
teroids, according to the current international guidelines alters the natur
al history of asthma, i.e. disease progression with regard to changes in lu
ng function and possible development of nonreversible airflow obstruction.